RBC Capital Reaffirms Their Buy Rating on Boston Scientific (BSX)
In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Boston Scientific (BSX – Research Report), with ...
RBC Capital Remains a Buy on Boston Scientific (BSX)
In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Boston Scientific (BSX – Research Report), ...
RBC Capital holds Boston Scientific stock Outperform rating
In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...
Top 30 global stock ideas from RBC Capital Markets analysts
The research team at RBC Capital Markets published their top 30 global stock ideas for 2025, ...
Capital Investment Advisors LLC Increases Stake in Boston Scientific Co. (NYSE:BSX)
Capital Investment Advisors LLC raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 12.2% in ...
TD Cowen maintains Boston Scientific buy rating, $110 target
TD Cowen reiterated a Buy rating for Boston Scientific (NYSE:BSX) stock, maintaining a price target of $110.00. The stock, currently trading at $98.78, has shown remarkable momentum, reaching new ...
medtechdive9d
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...
The TRADE3d
RBC Capital Markets names new head of European and Asian product, multi-asset agency solutions
RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager ...